SCHEMBL4229151

SCHEMBL4229151

CCCCN1CCCCC1Oc1ccc(C(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 2/20 0.47
SCN2A Q99250 2/20 0.47
SCN3A Q9NY46 2/20 0.47
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
CYP2D6 P10635 2/20 0.43
KCNH2 Q12809 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP3A4 P08684 1/20 0.43
PLA2G4B P0C869 2/20 0.43
RARB P10826 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTGER4 P35408 3/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CHRM2 P08172 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367095 0.80 NR5A1 (0.43) SCN1ASCN2ASCN3A
SCHEMBL7398553 0.80 KCNH2 (0.43) SCN1ASCN2ASCN3ACYP2D6KCNH2
SCHEMBL4234656 0.80 HRH3 (0.45) ALDH1A1CYP2D6KCNH2KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL7398909 0.79 KCNH2 (0.42) SCN1ASCN2ASCN3ACYP2D6KCNH2
SCHEMBL7392194 0.79 MAOB (0.44) SCN1ASCN2ASCN3ATSHRCYP2D6
SCHEMBL7402551 0.78 LTA4H (0.43) ALDH1A1HPGDKCNH2MEN1KMT2A
SCHEMBL7398807 0.78 LTA4H (0.43) ALDH1A1HPGDKCNH2MEN1KMT2A
SCHEMBL7403861 0.78 KMT2A (0.44) SCN1ASCN2ASCN3AALDH1A1HPGD
Hydrochloric Acid SCHEMBL7403380 0.78 MAOB (0.43) SCN1ASCN2ASCN3ATSHRCYP2D6
Oxalic Acid SCHEMBL7397763 0.77 KDM4E (0.54) ALDH1A1KMT2ASMN1; SMN2L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233910-A1 Npy antagonists, preparation and uses NPY1R, NPY5R, NPY2R SCN1A 929/4885SCN2A 1132/4885SCN3A 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.